Delivery Order SPE2DB24D9313-SPE2DB24FFFGW

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of the prescription drug Trikafta, and has an ultimate completion date of July 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (#4600082013) with DMS Pharmaceutical Group valued up to $4,999,999 for the supply of a broad range of pharmaceutical items to military health facilities globally. The delivery order is for the drug Trikafta, used to treat...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 delivery order contract is for the provision of the prescription drug Trikafta, used to treat cystic fibrosis. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This federal contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price delivery order, valued at $55,580.49, is for the supply of Trikafta, a specialty pharmaceutical product used to treat cystic fibrosis. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) on June 17, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price contract provides the DLA with Trikafta, a prescription medication used to treat cystic fibrosis. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group that allows the DLA to issue delivery orders for a...
This federal contract award, valued at $37,053.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order contract is for the supply of the drug Trikafta, a prescription medication used to treat cystic fibrosis. This award is made under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the drug Trikafta, with a completion date of February 13, 2024. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a separate indefinite delivery contract with DLA valued at up to $4,999,999 through 2025 to provide a wide range of pharmaceutical...
The federal contract award is valued at $55,580.49 and was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA. This single-award IDC, under the SPE2DB program, allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.83, is to provide the pharmaceutical product Trikafta, a specialty medication used to treat cystic fibrosis. The order has an ultimate completion date of November 20, 2024. DMS Pharmaceutical Group is a key supplier in the DLA's pharmaceutical supply chain,...
  • SPE2DB24D9313
    Indefinite Delivery Contract
  • SPE2DB24D9313-SPE2DB24FFFGW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the prescription drug Trikafta, which is used to treat cystic fibrosis. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. This single-award IDC allows DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 10/4/24, 9:11 AM